Bone densitometry firm Hologic of Waltham, MA, announced a two-for-onestock split effective March 25. Hologic's share price has risensteadily since last year, when Merck received marketing approvalfor its Fosamax osteoporosis drug, and the split will
Bone densitometry firm Hologic of Waltham, MA, announced a two-for-one
stock split effective March 25. Hologic's share price has risen
steadily since last year, when Merck received marketing approval
for its Fosamax osteoporosis drug, and the split will make the
company's stock more affordable. Hologic's stock was trading at
around $50 a share the week before the split. It had been trading
at around $14 a share last March (SCAN 12/27/95).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.